Henderson Group »

Celldex Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 26k 39.66
2023-09-30 $468k 17k 27.52
2023-06-30 $578k 17k 33.93
2023-03-31 $613k 17k 35.98
2022-12-31 $360k 8.1k 44.57
2022-03-31 $273k 8.1k 33.78
2021-12-31 $312k 8.1k 38.62
2021-09-30 $216k 4.0k 53.91